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Introduction
The potential to manipulate ovulation and spermiation of reared fish species, without which aquaculture would depend on broodstock, larvae, and fry from nature stock, is of great interest (Bromage 1995) . Many economically relevant fish species do not breed naturally in fish farms, possibly as https://doi.org/10.17221/161/2018-VETMED a result of stress or environmental conditions differing from their natural habitat, leading to inadequate supplies of quality juveniles for culture (Donaldson and Hunter 1983) . A constant supply of high-quality sexual products and fry is essential for profitable intensive aquaculture.
It is necessary to develop techniques for controlled reproduction in fish kept in fish farms to address complications associated with spawning synchronization, egg collection, seasonal reproduction, and reproductive dysfunction. Sustained drug release systems have enormous potential to overwhelm obstacles to successful reproduction of many fish species (Rather et al. 2013 ).
Hormonal treatment
In aquaculture, reproduction can be stimulated using manipulation of the environment or hormones (Bromage et al. 2001) . The first hormones used to induce spawning in captive fish were pituitary homogenates (hypophysation) (Fontenele 1955) . The efficiency of the treatment is on account of high luteinizing hormone (LH) amount. However, the major disadvantage is that pituitary homogenate used in hatcheries is generally not standardised with respect to the precise LH dose, due to the changeable LH amount in fish pituitary (Yaron 1995) .
Gonadotrophin releasing hormone (GnRH) is used for stimulation of gametogenesis (Lam 1982) . It has the advantage of acting at the upper level of the reproductive axis, specifically on the pituitary, supporting a more complete physiological provocation of the entire reproduction process (Duncan et al. 2003) , whereas pituitary homogenates act directly on the gonads. These treatments are believed to induce an enhancement of LH production. Nevertheless, adequate spawning often does not result, due to the short life of GnRH in the blood stream. This is caused by very quick degradation of GnRH by specific endopeptidases and non-specific exopeptidases (Goren et al. 1990) .
Successful approaches in the control of reproduction in a variety of many species have been reached by the administration of synthetic gonadotrophin releasing hormone analogue (GnRHa) (Crim and Bettles 1997) . Chemical synthesis of GnRHa eliminates the danger of transferof infectious diseases and allows for administration of precise dosages.
The process is simplified by the high grade of interspecies similarity in the GnRH peptide (Chen and Fernald 2008) . The biggest advantages of GnRHa over LH preparations are higher affinity to GnRH receptors and higher resistance to enzymatic cleavage (Well et al. 1992) , allowing GnRHa to remain in the blood stream for a longer time than do native forms of GnRH. As a result, longer and stronger stimulation of LH occurs (De Leeuw et al. 1988) .
Administered GnRHa induces the production and release of the endogenous LH (Breton et al. 1990 ), which in turn stimulates final oocyte maturation and ovulation (Nagahama and Yamashita 2008) via steroidogenesis and synthesis of the maturation inducing steroid (Goetz and Garczynski 1997) . GnRHa may be administered as saline injection or a sustained-release delivery system (Weil and Crim 1983) . Dependent upon the GnRHa type (e.g., leuprorelin, triptorelin, buserelin), fish species, and water temperature, one GnRHa injection evokes a LH wave that remains efficient for 12-72 hours (Carrillo et al. 2000) . In some fish species, a single injection of GnRHa is sufficient to promote spawning for 2-3 days post-treatment (Zakes and Demska-Zakes 2005) , but re-injections are frequently essential to provoke long lasting LH release and promote complete maturation and reproduction (Pankhurst et al. 1986; Dabrowski et al. 1994; Slater et al. 1995) . Multiple injections are stressful and often increase mortality of valuable broodstock. Stress may, in itself, inhibit the reproductive process and induce pathologies and even death (Schreck et al. 2001 ).
Delivery systems used for regulation of fish reproduction
Long acting preparations constitute a frontier area of science. These technologies have considerable benefits compared to conventional administration, containing controlled release, low toxicity, and better efficacy and convenience (Lin et al. 2014) . It has been demonstrated that GnRHa has a halflife of less than 30 min in the blood stream (Gothilf and Zohar 1991) . In contrast, the sustained release of GnRHa increases plasma GnRHa concentrations that may last for several weeks (Mylonas et al. 1995) . Sustained administration of GnRHa efficiently induces a sustained LH release. The induced endogenous LH release stimulates the go-https://doi.org/10.17221/161/2018-VETMED delivery system (Rhine et al. 1980 ). The EVAc is produced in the shape of solid implants that are administered intramuscularly (Brown et al. 1986 ). The release rate of EVAc implants can extend from 15 days (Gothilf 1990 ) to 5 weeks, depending on the structure (Zohar 1996) . EVAcs are simple to manufacture, and batches of 200-500 implants can be produced in a single preparation, minimizing GnRHa content variation among implants (Mylonas and Zohar 2000) . The implants remains useable for up to three years when stored dried at -20 °C . The EVAc systems ability to induce multiple ovulation was confirmed in European sea bass at 60 μg/kg (Fornies et al. 2001) , turbot Scophthalmus maximus at 25 μg/kg (Mugnier et al. 2000) , in Atlantic bluefin tuna Thunnus thunnus at 40-80 μg/kg (Rosenfeld et al. 2012) , and in great amberjack Seriola dumerili at 50 μg/kg (Jerez et al. 2018) . These results may be attributed to long term elevation of plasma LH caused by long acting release of GnRHa (Fornies et al. 2001 ).
Poly(lactic-co-glycolic acid) microparticles
Microparticle is a dosage form that can be used for delivering of drugs by many ways and efficaciously manage the release of agent (Donbrow 1991; Birnbaum and Brannon-Peppas 2004) . The name microparticle refers to a particle of diameter 1-1000 µm (Birnbaum and Brannon-Peppas 2004) . Microparticles can be extremely helpful to protect the encapsulated agent against enzymatic degradation. Other advantages of microparticles are the possibility of controlled release of the agent, local delivery of the incorporated agent over intervals ranging from a few hours to several weeks, and simple administration compared to normally used forms of long-acting preparations, such as implants that are often used in aquaculture (Siepmann and Siepmann 2006) .
A large range of natural as well as synthetic biodegradable polymers have been examined for use as matrix for microparticles (Hoffman 2008) . Among them, the thermoplastic aliphatic poly(esters) as for example poly(lactic-co-glycolic acid); (PLGA) have caused concern owing to their extremely good tissue biocompatibility, biodegradability in the body (Lewis 1990 ) and show high flexibility in the ennads more effectively than externally administered LH (Mylonas and Zohar 2000) . Sustained delivery of GnRHa is advantageous compared to conventional dosage forms (Mylonas et al. 2007) . Particularly in fishes with asynchronous ovarian development, sustained administration of GnRHa stimulates a long lasting elevation of plasma LH that causes multiple spawnings Carrillo et al. 2000) .
The first long acting preparation for the manipulation of spawning in fish used was cholesterol (Weil and Crim 1983; Carolsfeld et al. 1988) . The agent was imbedded in cholesterol pellets with included cellulose to slow the release. Cholesterol pellets with imbedded mammalian GnRHa (mGnRHa) released an initial burst. After this initial burst, a sustained release follows that may last for over 28 days . The disadvantage of this system is a significant variation in GnRHa release from individual pellets (Carolsfeld et al. 1988) . Moreover, there were concerns that cholesterol as an active biomolecule and a precursor to steroid hormone synthesis may influence gonad function (Mylonas and Zohar 2000) . On the other hand, administration of cholesterol pellets is simple, and they can be stored without loss of bioactivity at room temperature for at least 4 weeks (Garcia 1996) . Its positive effect on induction of maturation was confirmed in many species of fish including rainbow trout Oncorhynchus mykiss (Crim et al. 1983) , herring Clupea harengus pallasi (Carolsfeld et al. 1988) , sea bass Dicentrarchus labrax (Almendras et al. 1988) , milkfish Chanos chanos (Marte et al. 1988) , Pacific white snook Centropomus viridis (Ibarra-Castro et al. 2017) , and beluga Huso huso (Aramli et al. 2017) .
Following the success of cholesterol pellets containing mGnRHa, commercially available cholesterol pellets containing salmon GnRHa (sGnRHa) were developed (Ovaplant, Syndel International). With this preparation, 40-60% of the sGnRHa is released during the first day, and the rest of the drug is released over the ensuing 7-21 days (U.S. (Kuradomi et al. 2017) .
A non-degradable co-polymer of ethylene and vinyl acetate (EVAc) is also used as a sustained (Harikrishnan et al. 2012 ) encapsulated in PLGA were successfully used in fish and offered effective protection against pathogens.
Majority of biodegradable polymers decompose via hydrolysis to biologically tolerable and progressively minor compounds. In PLGA, the polymer eventually breaks down into lactic and glycolic acid, which enter the Krebs cycle. Afterwards it is further decomposed to carbon dioxide and water (Houchin and Topp 2009) .
Microspheres of PLGA and other polymers are usually formed by solvent evaporation (Wakiyama et al. 1981; Bai et al. 2001; Ruan and Feng 2003) . Frequently a double emulsion is used in which medicament that will be encapsulated is primarily dissolved in water. The aqueous phase is dissipated in an organic solvent (Dichloromethane) that includes the degradable polymer, and a water/oil emulsion is formed. Dispersion of the first emulsion in a steady aqueous medium, normally with poly(vinyl alcohol) as stabilizer, forming the final water/oil/water double emulsion. Microspheres are produced when the dichloromethane vaporizes and the polymer solidifies, incorporating the encapsulated pharmaceutical agent (O'Donnell and McGinity 1997).
Factors affecting drug release
Drug release kinetic is affected by the form of the matrix in which the active substance is incorporated and the chemical characteristics of the polymer and the medicament (Freiberg and Zhu 2004) . A consistent release rate over time is desirable but release profiles may consist of an initial burst of medication released from the microparticle uppermost layer followed by a constant sustained release that depends on diffusion as well as on decomposition (Mogi et al. 2000) .
The method of particle fabrication governs the incorporation and release of the therapeutic agent. A complex range of elements containing the kind of polymer, its molecular weight, the co-polymer structure, the nature of pharmaceutical ingredients incorporated to the microparticle mixture (therapeutic agent stabilization), and microparticle size can affect the release rate (Raman et al. 2005) .
The kind of polymer employed in microparticle production and the process in which it breaks down surely affects therapeutic agent release kinetics (von Burkersroda et al. 2002) . Bulk-eroding polymer microspheres such as PLGA are frequently distinguished in release of up to 50% of the complete therapeutic agent load over the first few hours after application. This initial burst is succeeded by slow release and occasionally a third stage during which the remainder is released rapidly due to the polymer decomposition (O'Donnell and McGinity 1997) .
Both acidic and strongly alkaline media accelerate degradation of PLGA (Holy et al. 1999) . Nevertheless, the contrast between neutral and slightly acidic environment is less significant because of autocatalysis by the carboxylic end groups (Zolnik and Burgess 2007) . Enzymatic degradation also influences drug release. Poly(lactic-co-glycolic acid) is decomposed firstly via hydrolysis, but it has also been proposed that enzymatic decomposition can affect the drug release from the microparticles. Lack of uniformity in vivo makes it complicated to compare the contribution of obtainable enzymes to the degradation process (Cai et al. 2003) .
Conclusions
Sustained delivery systems for GnRHa have shown to be effective methods for hormonal regulation of fish spawning. Apart from the type of hormonal treatment, the form of its administration is a major factor influencing the efficacy of the preparation. In the case of conventional drug release treatment, the hormonal preparation is dissolved in physiological saline, but a significant obstacle is the rapid enzymatic degradation of the administered peptide reducing its efficacy (Goren et al. 1990 ). Therefore, multiple administration is required to maintain the effective level of the preparation, otherwise the plasma concentration of the peptide falls below the therapeutic level (Schreck et al. 2001 ). The development of advanced drug delivery system opens new possibilities for effective administration of biologically active substances in the structure of microparticles enabling the release of bounded hormonal substances at the desired dose and for a set time.
Drug delivery using PLGA is an interesting field with extensive potential for biomedical investigation. They are easily produced and can preserve the agent from degradation and increase its stability. Microparticles of PLGA can increase the effica-https://doi.org/10.17221/161/2018-VETMED cy of treatment through long acting of the drug. It is approved by the US Food and Drug Administration and European Medicine Agency in diverse long acting systems. PLGA microparticles show potential as a long acting preparation in fish reproduction.
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